SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-287010
Filing Date
2020-11-05
Accepted
2020-11-05 17:24:13
Documents
45
Period of Report
2020-11-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d64875d8k.htm   iXBRL 8-K 36457
2 EX-99.1 d64875dex991.htm EX-99.1 40733
6 GRAPHIC g64875ex99_1s10g1.jpg GRAPHIC 386253
7 GRAPHIC g64875ex99_1s11g1.jpg GRAPHIC 345355
8 GRAPHIC g64875ex99_1s12g1.jpg GRAPHIC 360494
9 GRAPHIC g64875ex99_1s13g1.jpg GRAPHIC 284282
10 GRAPHIC g64875ex99_1s14g1.jpg GRAPHIC 275408
11 GRAPHIC g64875ex99_1s15g1.jpg GRAPHIC 217207
12 GRAPHIC g64875ex99_1s16g1.jpg GRAPHIC 246090
13 GRAPHIC g64875ex99_1s17g1.jpg GRAPHIC 275037
14 GRAPHIC g64875ex99_1s18g1.jpg GRAPHIC 241767
15 GRAPHIC g64875ex99_1s19g1.jpg GRAPHIC 361302
16 GRAPHIC g64875ex99_1s1g1.jpg GRAPHIC 382789
17 GRAPHIC g64875ex99_1s20g1.jpg GRAPHIC 368911
18 GRAPHIC g64875ex99_1s21g1.jpg GRAPHIC 522737
19 GRAPHIC g64875ex99_1s22g1.jpg GRAPHIC 356187
20 GRAPHIC g64875ex99_1s23g1.jpg GRAPHIC 339198
21 GRAPHIC g64875ex99_1s24g1.jpg GRAPHIC 362339
22 GRAPHIC g64875ex99_1s25g1.jpg GRAPHIC 352239
23 GRAPHIC g64875ex99_1s26g1.jpg GRAPHIC 353782
24 GRAPHIC g64875ex99_1s27g1.jpg GRAPHIC 411079
25 GRAPHIC g64875ex99_1s28g1.jpg GRAPHIC 317303
26 GRAPHIC g64875ex99_1s29g1.jpg GRAPHIC 380519
27 GRAPHIC g64875ex99_1s2g1.jpg GRAPHIC 968636
28 GRAPHIC g64875ex99_1s30g1.jpg GRAPHIC 570026
29 GRAPHIC g64875ex99_1s31g1.jpg GRAPHIC 389546
30 GRAPHIC g64875ex99_1s32g1.jpg GRAPHIC 339781
31 GRAPHIC g64875ex99_1s3g1.jpg GRAPHIC 381064
32 GRAPHIC g64875ex99_1s4g1.jpg GRAPHIC 443304
33 GRAPHIC g64875ex99_1s5g1.jpg GRAPHIC 402857
34 GRAPHIC g64875ex99_1s6g1.jpg GRAPHIC 417647
35 GRAPHIC g64875ex99_1s7g1.jpg GRAPHIC 489482
36 GRAPHIC g64875ex99_1s8g1.jpg GRAPHIC 380033
37 GRAPHIC g64875ex99_1s9g1.jpg GRAPHIC 484134
  Complete submission text file 0001193125-20-287010.txt   17312982

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA oyst-20201105.xsd EX-101.SCH 3072
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE oyst-20201105_lab.xml EX-101.LAB 18887
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oyst-20201105_pre.xml EX-101.PRE 11861
38 EXTRACTED XBRL INSTANCE DOCUMENT d64875d8k_htm.xml XML 3477
Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39112 | Film No.: 201291633
SIC: 2836 Biological Products, (No Diagnostic Substances)